UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

European journal of immunology, 2003-10, Vol.33 (10), p.2706-2716

2003

Link zum Volltext

Verfügbarkeit prüfen

PD-L1-Deficient Mice Show That PD-L1 on T Cells, Antigen-Presenting Cells, and Host Tissues Negatively Regulates T Cells

Proceedings of the National Academy of Sciences - PNAS, 2004-07, Vol.101 (29), p.10691-10696

2004

Link zum Volltext

Verfügbarkeit prüfen

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model

Cancer Immunology, Immunotherapy, 2011-04, Vol.60 (4), p.547-558

2011

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes

Journal of Immunology, 2005-12, Vol.175 (11), p.7372-7379

2005

Link zum Volltext

Verfügbarkeit prüfen

PD‐L1 and PD‐L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis

European Journal of Immunology, 2006-01, Vol.36 (1), p.58-64

2006

Link zum Volltext

Verfügbarkeit prüfen

Tissue expression of PD-L1 mediates peripheral T cell tolerance

The Journal of experimental medicine, 2006-04, Vol.203 (4), p.883-895

2006

Link zum Volltext

Verfügbarkeit prüfen

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice

International immunology, 2011-02, Vol.23 (2), p.149-158

2011

Link zum Volltext

Verfügbarkeit prüfen

Negative co-receptors on lymphocytes

Current Opinion in Immunology, 2002-06, Vol.14 (3), p.391-396

2002

Link zum Volltext

Verfügbarkeit prüfen

Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions

Blood, 2006-04, Vol.107 (8), p.3181-3188

2006

Link zum Volltext

Verfügbarkeit prüfen

The SLAM family member CD48 ( Slamf2 ) protects lupus-prone mice from autoimmune nephritis

Journal of autoimmunity, 2011-08, Vol.37 (1), p.48-57

2011

Link zum Volltext

Verfügbarkeit prüfen

Distinct changes in adult lymphopoiesis in Rag2−/− mice fully reconstituted by α4-deficient adult bone marrow cells

Experimental hematology, 2008-08, Vol.36 (8), p.1004-1013

2008

Link zum Volltext

Verfügbarkeit prüfen

NKT activation together with blockade of PD-L1 pathway lead to enhanced tumor responses (40.32)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.40-40.32

2009

Link zum Volltext

Verfügbarkeit prüfen

Distinct changes in adult lymphopoiesis in Rag2-/- mice fully reconstituted by alpha4-deficient adult bone marrow cells

Experimental hematology, 2008-08, Vol.36 (8), p.1004

2008

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes1

The Journal of immunology (1950), 2005-12, Vol.175 (11), p.7372-7379

2005

Link zum Volltext

Verfügbarkeit prüfen

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Nature immunology, 2001-03, Vol.2 (3), p.261-268

2001

Link zum Volltext

Verfügbarkeit prüfen

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

Oncotarget, 2015-10, Vol.6 (31), p.31344-31359

2015

Link zum Volltext

Verfügbarkeit prüfen

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P449-P449, Article P449

2015

Link zum Volltext

Verfügbarkeit prüfen

The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P452-P452, Article P452

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Animals
(13)
Mice
(12)
Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Immunology
(9)
B7-H1 Antigen
(8)
Mice, Knockout
(6)
Programmed Cell Death 1 Ligand 2 Protein
(6)
T-Lymphocytes - Immunology
(6)
Mice, Inbred C57bl
(5)
Peptides - Immunology
(5)
Humans
(4)
Immunotherapy
(4)
Membrane Glycoproteins
(4)
Membrane Glycoproteins - Immunology
(4)
Mice, Inbred Balb C
(4)
Peptides - Metabolism
(4)
Programmed Cell Death 1 Receptor
(4)
Antigens
(3)
Antigens, Cd - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

PD-L1-Deficient Mice Show That PD-L1 on T Cells, Antigen-Presenting Cells, and Host Tissues Negatively Regulates T Cells

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model

Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes

PD‐L1 and PD‐L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis

Tissue expression of PD-L1 mediates peripheral T cell tolerance

Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice

Negative co-receptors on lymphocytes

Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions

The SLAM family member CD48 ( Slamf2 ) protects lupus-prone mice from autoimmune nephritis

Distinct changes in adult lymphopoiesis in Rag2−/− mice fully reconstituted by α4-deficient adult bone marrow cells

NKT activation together with blockade of PD-L1 pathway lead to enhanced tumor responses (40.32)

Distinct changes in adult lymphopoiesis in Rag2-/- mice fully reconstituted by alpha4-deficient adult bone marrow cells

Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes1

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

Suchergebnisse filtern